2. Nautilus Biotechnology Inc. (NASDAQ:NAUT)
Closing Share Price $1.9600
Daily Increase 24.84%
Market Cap $249.42 Million
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) develops a platform for measuring and analyzing proteins. Its technology combines instruments, reagents, consumables, and software, positioning the company within the research infrastructure supporting life sciences. The business is distinct from a biotechnology company developing a single therapeutic candidate.
The shares climbed 24.84% to finish at $1.9600. That substantial increase, combined with a sub-$2 price, produced a score of 12.67 and second place in the shortlist. Reported market capitalization was approximately $249.42 million.
Reported trailing revenue stood at approximately $190,000, while the trailing net loss was $56.52 million. Those figures highlight the early commercial stage of the business. Investors researching biotechnology and life sciences stocks should watch platform adoption, customer spending, and the ability to convert scientific interest into meaningful recurring sales.
